Balsalazide clinical trials
How each study uses balsalazide is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- 18 Jul 2000 · COLAZAL · NDA 020610 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
5 studies that test it; most in 2004 (2)
| Year | Studies |
|---|---|
| 2004 | 2 |
| 2005 | 1 |
| 2006 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 5 · Other 0
Bausch Health Americas, Inc. (2) · Roxane Laboratories (2) · Mylan Pharmaceuticals Inc (1)
Related medicines
As reviewed, each with the page that says it.
Studies
Open first, then newest update. How each study uses balsalazide is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 5
- Fasting Study of Balsalazide Disodium Capsules 750 mg and Colazal® Capsules 750 mgCompletedPhase 1Mylan Pharmaceuticals IncNCT00648531Written as Balsalazide Disodium Capsules 750 mgHow we know
- Balsalazide Disodium vs. Mesalamine in Mildly to Moderately Active Ulcerative ColitisCompletedPhase 3Bausch Health Americas, Inc.NCT00408174Written as Balsalazide disodiumHow we know
- Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis StudyCompletedPhase 3Bausch Health Americas, Inc.NCT00486031Written as Balsalazide DisodiumHow we know
- A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Balsalazide Disodium 750 mg Capsules Under Fasting ConditionsCompletedNot applicableRoxane LaboratoriesNCT00618202Written as BalsalazideHow we know
- Bioequivalency Study of Balsalazide Capsules Under Fasting ConditionsCompletedNot applicableRoxane LaboratoriesNCT00618228Written as BalsalazideHow we know
As the comparator · 1 — what is tested is compared with balsalazide
Codes
What other systems call balsalazide · ClinicalTrials.gg INT003101
- MeSH (NLM) C038637balsalazideConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) P80AL8J7ZPBALSALAZIDEConfirmed FDA, NLM, Wikidata
- RxNorm 18747Confirmed FDA, Wikidata
- Wikidata Q347337balsalazideConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C65247BalsalazideOne source FDA
- DrugBank DB01014One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C038637 | balsalazide | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | P80AL8J7ZP | BALSALAZIDE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 18747 | — | Confirmed FDA, Wikidata |
| Wikidata | Q347337 | balsalazide | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C65247 | Balsalazide | One source FDA |
| DrugBank | DB01014 | — | One source Wikidata |
Also registered as balsalazide disodium (UNII 1XL6BJI034 · RxNorm 153718).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.